The stock of Cutera, Inc. (NASDAQ:CUTR) hit a new 52-week high and has $17.71 target or 7.00% above today’s $16.55 share price. The 8 months bullish chart indicates low risk for the $227.74 million company. The 1-year high was reported on Nov, 28 by Barchart.com. If the $17.71 price target is reached, the company will be worth $15.94 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 66,397 shares traded hands or 8.41% up from the average. Cutera, Inc. (NASDAQ:CUTR) has risen 33.11% since April 25, 2016 and is uptrending. It has outperformed by 27.09% the S&P500.
Analysts await Cutera, Inc. (NASDAQ:CUTR) to report earnings on February, 13. They expect $0.24 EPS, up 41.18% or $0.07 from last year’s $0.17 per share. CUTR’s profit will be $3.30 million for 17.24 P/E if the $0.24 EPS becomes a reality. After $0.12 actual EPS reported by Cutera, Inc. for the previous quarter, Wall Street now forecasts 100.00% EPS growth.
According to Zacks Investment Research, “Cutera Inc designs, develops, manufactures and markets the CoolGlide family of products for use in laser and other light-based aesthetic applications. The original CoolGlide CV provides permanent hair reduction on all skin types. The second generation CoolGlide Excel incorporated features that added the capability to treat a variety of vascular lesions, which include facial telangiectasia, spider and reticular leg veins. The CoolGlide Vantage added non-ablative skin therapy to the range of applications offered by the system.”
Insitutional Activity: The institutional sentiment increased to 1.5 in Q2 2016. Its up 0.15, from 1.35 in 2016Q1. The ratio improved, as 5 funds sold all Cutera, Inc. shares owned while 21 reduced positions. 10 funds bought stakes while 25 increased positions. They now own 8.57 million shares or 2.67% less from 8.81 million shares in 2016Q1.
Fmr Limited Liability Co has 259,600 shares for 0% of their US portfolio. The New York-based D E Shaw & has invested 0% in Cutera, Inc. (NASDAQ:CUTR). Dalton Greiner Hartman Maher & last reported 227,992 shares in the company. Blackrock Fund Advisors has 0% invested in the company for 307,105 shares. Vanguard Group owns 555,088 shares or 0% of their US portfolio. The North Carolina-based Wedge Mgmt L L P Nc has invested 0% in Cutera, Inc. (NASDAQ:CUTR). Morgan Stanley reported 20,994 shares or 0% of all its holdings. Royal Retail Bank Of Canada holds 0% of its portfolio in Cutera, Inc. (NASDAQ:CUTR) for 4,937 shares. State Street Corp has 165,660 shares for 0% of their US portfolio. Bnp Paribas Arbitrage accumulated 452 shares or 0% of the stock. Millennium Mngmt Limited Liability Company accumulated 21,453 shares or 0% of the stock. Gsa Capital Ptnrs Limited Liability Partnership owns 49,200 shares or 0.03% of their US portfolio. Manufacturers Life Insurance The accumulated 6,934 shares or 0% of the stock. Fincl Bank Of Montreal Can accumulated 0% or 8,663 shares. Bridgeway owns 70,700 shares or 0.01% of their US portfolio.
Insider Transactions: Since May 31, 2016, the stock had 0 buys, and 3 selling transactions for $1.13 million net activity. $350,081 worth of Cutera, Inc. (NASDAQ:CUTR) was sold by CONNORS KEVIN P on Tuesday, May 31. SANTILLI RONALD J also sold $154,068 worth of Cutera, Inc. (NASDAQ:CUTR) on Tuesday, November 15.
More recent Cutera, Inc. (NASDAQ:CUTR) news were published by: Seekingalpha.com which released: “Cutera Still Looks Cheap – But Still Has Questions” on September 08, 2016. Also Zacks.com published the news titled: “Why Cutera (CUTR) Could Shock the Market Soon” on November 22, 2016. Seekingalpha.com‘s news article titled: “Cutera: Is This Time Different?” with publication date: January 20, 2016 was also an interesting one.
CUTR Company Profile
Cutera, Inc., incorporated on August 10, 1998, is a medical device company. The Firm is engaged in the design, development, manufacture, marketing and servicing of laser and other energy aesthetics systems for practitioners across the world. The Firm offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers. Each of its laser and other energy platforms consists of one or more hand pieces and a console that incorporates a universal graphical user interface, a laser or other energy module, control system software and high voltage electronics.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.